Abstract
Zinc is a trace metal and acts as an active component of various enzymes. Zinc deficiency has been suggested to be associated with the development of diabetes. The present study investigated the role of zinc supplementation on prevention of diabetic conditions. A double-disease model mimicking hyperlipidemia and type 2 diabetes was created by applying high-fat diet and streptozotocin (STZ) to Wistar rats. We demonstrated that zinc supplementation improved symptoms of diabetes such as polydipsia and increased serum level of high-density lipoprotein cholesterol, indicating that zinc supplementation has a potential beneficial effect on diabetic conditions. The level of maldondialdehyde (MDA), an oxidative stress marker, was reduced in liver by zinc supplementation in high fat-fed rats with or without STZ injection. Meanwhile, we observed an increase in the expression of metallothioneins (MTs) in liver of rats treated with zinc. This suggests that the induction of MTs in liver, which has been shown to be important in scavenging free radicals, could be one of the underlying mechanisms of zinc supplementation on reducing MDA levels in liver. Finally, we found that zinc levels in liver were increased while there was no change in serum zinc levels, indicating that local zinc level might be a critical factor for the induction of MTs. Also, the level of MTs could potentially be an index of zinc bioavailability. Taken together, these results suggest that both zinc and MT could play an important role in balancing nutrition and metabolism to prevent diabetic development.
Similar content being viewed by others
References
Anderson RA, Roussel AM, Zouari N, Mahjoub S, Matheau JM, Kerkeni A (2001) Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus Journal of the American. J Am Coll Nutr 20:212–218
Baraboy VA, Petrina LG (2003) Metallothioneins: the structure and action mechanisms. Ukr Biokhim Zh 75:28–36
Barbato JC, Catanescu O, Murray K, DiBello PM, Jacobsen DW (2007) Targeting of metallothionein by l-homocysteine: a novel mechanism for disruption of zinc and redox homeostasis. Arterioscler Thromb Vasc Biol 27:49–54
Barter PJ, Rye KA (1996) High density lipoproteins and coronary heart disease. Atherosclerosis 121:1–12
Begin-Heick N, Dalpe-Scott M, Rowe J, Heick HM (1985) Zinc supplementation attenuates insulin secretory activity in pancreatic islets of the ob/ob mouse. Diabetes 34:179–184
Beletate V, El Dib RP, Atallah AN (2007) Zn supplementation for the prevention of type 2 diabetes mellitus. Cochrane Database Syst Rev 24: CD005525
Cao J, Henry PR, Davis SR, Cousins RJ, Miles RD, Littell RC, Ammerman CB (2002) Relative bioavailability of organic zinc sources based on tissue zinc and metallothionein in chicks fed conventional dietary zinc concentrations. Anim Feed Sci Tech 101:161–170
Chen MD, Liou SJ, Lin PY, Yang VC, Alexander PS, Lin WH (1998) Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice. Biol Trace Elem Res 61:303–311
Chien K, Cai T, Hsu H, Su T, Chang W, Chen M, Lee Y, Hu FB (2009) A prediction model for type 2 diabetes risk among Chinese people. Diabetologia 52:443–450
Coccheri S (2007) Approaches to prevention of cardiovascular complications and events in diabetes mellitus. Drugs 67:997–1026
Czernichow S, Couthouis A, Bertrais S, Vergnaud AC, Dauchet L, Galan P, Hercberg S (2006) Antioxidant supplementation does not affect fasting plasma glucose in the supplementation with antioxidant vitamins and minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations. Am J Clin Nutr 84:395–399
Deedwania P (2011) Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating beta-blockers. J Clin Hypertens 13:52–59
Erdal N, Gurgul S, Kavak S, Yildiz A, Emre M (2011) Deterioration of bone quality by streptozotocin (STZ)-induced type 2 diabetes mellitus in rats. Biol Trace Elem Res 140:342–353
Grungreiff K, Reinhold D (2005) Liver cirrhosis and "liver" diabetes mellitus are linked by zinc deficiency. Med Hypotheses 64:316–317
Hussein AM, Omar NM, Sakr H, Elsamanoudy AZ, Shaheen D (2011) Modulation of metabolic and cardiac dysfunctions by insulin sensitizers and angiotensin receptor blocker in rat model of type 2 diabetes mellitus. Can J Physiol Pharmacol 89:216–226
Irato P, Santovito G, Piccinni E, Albergoni V (2001) Oxidative burst and metallothionein as a scavenger in macrophages. Immunol Cell Biol 79:251–254
Ismael PH, Yesica AF, Ricardo MZ (2010) Analysis of the membrane fluidity of erythrocyte ghosts in diabetic, spontaneously hypertensive rats. Acta Diabetologica 47:47–55
Kehkashan P, Rashid Khan M, Mujeeb M, Siddiqui WA (2010) Protective effects of Pycnogenol (R) on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats. Chem Biol Interact 186:219–227
Lastra G, Manrique C (2007) The expanding role of oxidative stress, renin angiotensin system, and beta-cell dysfunction in the cardiometabolic syndrome and type 2 diabetes mellitus. Antioxid Redox Signal 9:943–954
Marreiro DN, do Perpetuo Socorro C, Martins M, de Sousa SS, Ibiapina V, Torres S, Pires LV, do Nascimento Nogueira N, Lima JM, do Monte SJ (2007) Urinary excretion of zinc and metabolic control of patients with diabetes type 2. Biol Trace Elem Res 120:42–50
Matsunami T, Sato Y, Sato T, Ariga S, Shimomura T, Yukawa M (2010) Oxidative stress and gene expression of antioxidant enzymes in the streptozotocin-induced diabetic rats under hyperbaric oxygen exposure. Int J Clin Exp Pathol 3:177–188
Meika F, Peter P, Samir S (2010) Effects of zinc on plasma lipoprotein cholesterol concentrations in humans: a meta-analysis of randomised controlled trials. Atherosclerosis 210:344–352
Meika F, Samir S (2010) Zinc and redox signaling: perturbations associated with cardiovascular disease and diabetes mellitus. Antioxid Redox Signal 13:1549–1573
Mitsutake R, Miura SI, Zhang B, Saku K (2010) HDL-associated factors provide additional prognostic information for coronary artery disease as determined by multi-detector row computed tomography. Int J Cardiol 143:72–78
Pan HZ, Zhang L, Guo MY (2010) The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetol 47:71–76
Roussel AM, Kerkeni A, Zouari N, Mahjoub S, Matheau JM, Anderson RA (2003) Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J Am Coll Nutr 22:316–321
Souto SB, Souto EB, Braga DC, Medina JL (2011) Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM). Eur J Clin Pharmacol 67:653–661
Sprietsma JE, Schuitemaker GE (1994) Diabetes can be prevented by reducing insulin production. Med Hypotheses 42:15–23
Suzuki H, Asakawa A, Li JB, Tsai M, Amitani H, Ohinata K, Komai M, Inui A (2011) Zinc as an appetite stimulator—the possible role of zinc in the progression of diseases such as cachexia and sarcopenia. Recent Pat Food Nutr Agric 3:226–231
Viarengo A, Burlando B, Ceratto N, Panfoli I (2000) Antioxidant role of metallothioneins: a comparative overview. Cell Mol Biol 46:407–417
Wong KC, Wang ZQ (2006) Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract 73:126–134
Wu YT, Sun Z, Che SP, Chang H (2004) Effects of zinc and selenium on the disorders of blood glucose and lipid metabolism and its molecular mechanism in diabetic rats. Wei Sheng Yan Jiu 33:70–73
Yu M, Zhou W, Song Y, Yu F, Li D, Na S, Zou G, Zhai M, Xie C (2011) Development of mesenchymal stem cell-implant complexes by cultured cells sheet enhances osseointegration in type 2 diabetic rat model. Bone 49:387–394
Acknowledgment
Our work was supported by the National Science Foundation of China (30370669).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, X., Li, H., Fan, Z. et al. Effect of zinc supplementation on type 2 diabetes parameters and liver metallothionein expressions in Wistar rats. J Physiol Biochem 68, 563–572 (2012). https://doi.org/10.1007/s13105-012-0174-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13105-012-0174-y